Description
Triple-hormone agonist peptide studied in metabolic and appetite regulation research. For laboratory and in-vitro research use only.
Retatrutide is a novel triple-hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, investigated for its multi-pathway effects on metabolic regulation.
Research focuses on understanding how triple-receptor activation enhances glucose control, energy expenditure, and weight management beyond dual-agonist approaches.
Laboratory studies examine its mechanisms in pancreatic function, hepatic metabolism, and adipose tissue remodelling using in-vitro systems and animal models.
The compound is studied to elucidate the synergistic effects of activating three distinct metabolic pathways concurrently.
Buy Retatrutide research peptide in the UK from MyPep Biotech.
Every batch of Retatrutide is HPLC-tested to 99%+ purity with a Certificate of Analysis available, held in UK stock and dispatched same-day — supplied for laboratory and in-vitro research use only.
- Genuine UK stock — dispatched from the UK
- Same-day dispatch on paid orders
- HPLC-tested for verified purity
- Secure, tracked UK delivery
Retatrutide is a synthetic peptide studied as a triple agonist, engaging the GLP-1, GIP and glucagon receptors simultaneously.
This triple-receptor mechanism distinguishes it from single- or dual-agonist compounds and has made it a frequent subject of metabolic research over the past several years (retatrutide research).
MyPep Biotech is a UK research peptide supplier providing the Retatrutide peptide (reta peptide uk) for laboratory research purposes only, with HPLC-verified purity and a batch-specific Certificate of Analysis included with every order.
The Research Interest Behind Triple-Receptor Agonism
Much of the published research on Retatrutide focuses on how combined GLP-1, GIP and glucagon receptor activity affects energy expenditure and substrate metabolism in preclinical models, compared with compounds that act on only one or two of these pathways.
Researchers studying metabolic regulation are often interested in whether engaging the glucagon receptor alongside the incretin pathways changes the balance between appetite suppression and energy expenditure observed in a model system.
This makes Retatrutide a useful comparator compound in studies examining receptor-selectivity questions within the broader GLP-1/GIP peptide class.
Molecular Characteristics
Retatrutide is a modified peptide sequence incorporating a fatty-acid moiety intended to extend its half-life by promoting albumin binding, a design approach shared with several other long-acting incretin-pathway peptides.
This structural feature is one reason the compound is studied alongside Semaglutide and Tirzepatide in comparative pharmacokinetic research, even though the receptor-binding profile differs.
Purity and Batch Documentation
Every batch of Retatrutide supplied by MyPep Biotech is tested by HPLC to confirm purity, with the resulting chromatogram and stated purity percentage provided as part of the Certificate of Analysis.
We recommend researchers retain the COA alongside their lab records for each vial used in a study, both for internal quality control and for any publication or audit requiring traceability of research materials.
Storage and Handling Guidance
Lyophilised Retatrulide should be stored at -20°C, protected from light and moisture, and used within the stability window indicated on its Certificate of Analysis.
Once reconstituted, peptide solutions are generally less stable and should be refrigerated and used within the timeframe appropriate to the compound — researchers should consult our Reconstitution and Storage guide for calculation support and general handling practices before beginning a protocol.
Common Research Applications
Within the published literature, Retatrutide has primarily been examined in the context of:
- Comparative studies of receptor-selective versus multi-receptor incretin agonism
- Energy expenditure and substrate utilisation models
- Glucose regulation research alongside other GLP-1/GIP-pathway compounds
- Pharmacokinetic comparison studies against single- and dual-agonist peptides
Researchers designing a study involving Retatrutide should review current published literature for methodology and dosing frameworks used in comparable in-vitro or animal-model research, since protocols vary significantly by study objective.
Clinical Trial Background
Retatrutide is an investigational triple-hormone receptor agonist originally developed by Eli Lilly, and has been evaluated in a Phase 2 clinical trial exploring its use in weight loss research.
In that trial, participants receiving the highest dose tested experienced the greatest reduction in body weight, and the compound’s GIP-receptor activity has been described as glucose dependent, meaning its insulin-related signalling responds to circulating glucose levels rather than acting independently of them.
These findings relate to clinical research conducted by the originating manufacturer and are referenced here for research-context purposes only.
Research Use Only
Retatrutide supplied by MyPep Biotech is intended strictly for laboratory research and is not for human or animal use, consumption, or therapeutic application of any kind.
It is not manufactured or labelled as a drug, supplement or medical product.
Researchers are responsible for ensuring appropriate ethical and institutional approval is in place before beginning any study involving this compound.
Ordering Retatrutide From MyPep Biotech
Each order ships with its matching Certificate of Analysis and is dispatched via tracked UK courier.
If your research protocol requires a specific concentration, quantity or documentation format, contact our team before ordering so we can confirm availability against your current batch stock.
Frequently Asked Questions
Where can I buy Retatrutide peptide in the UK?
You can buy Retatrutide from MyPep Biotech, a UK-based research peptide supplier.
Every batch of Retatrutide is HPLC-tested to 99%+ purity, held in UK stock, dispatched same-day and supplied with a batch-specific Certificate of Analysis for laboratory research use only.
Is Retatrutide HPLC-tested?
Yes.
Retatrutide supplied by MyPep Biotech is verified by High-Performance Liquid Chromatography (HPLC) to confirm identity and purity, with the result recorded on the Certificate of Analysis for that batch.
See our HPLC purity guide for how to read the result.
How should Retatrutide be stored and reconstituted?
Lyophilised Retatrutide should be stored cool, dark and dry, and reconstituted with bacteriostatic water before laboratory use.
Our peptide reconstitution calculator converts the vial contents and diluent volume into a working concentration.
Retatrutide is for research use only.
Related research resources
- GLP-1 Research Peptides Guide →
- What Are Peptides? A Researcher’s Guide →
- HPLC Purity Guide →
- Peptide Storage Guide →
- Peptide Reconstitution Calculator →
- Research Peptides UK Sourcing Guide →
Buy Retatrutide 20mg in the UK
Researchers looking to buy Retatrutide 20mg UK-side can order Retatrutide 20mg online directly from MyPep Biotech, a UK-based research peptide supplier.
If you are deciding where to buy Retatrutide 20mg or looking for the best place to buy Retatrutide 20mg for laboratory work, we hold Retatrutide 20mg in genuine UK stock, HPLC-tested to 99%+ purity with a batch-specific Certificate of Analysis, and dispatch same-day.
As an established UK peptide store and peptide company, we make it straightforward to purchase peptides UK-side with tracked delivery.
Retatrutide 20mg is supplied strictly for laboratory and in-vitro research use only.
For general context on sourcing, buying peptides UK-side and how to get peptides from a verified peptide supplier, see our research peptides UK guide.
We do not provide administration or dosing information of any kind.
Helpful research resources
- Research peptides UK: sourcing & buying guide →
- Bacteriostatic water guide →
- Peptide storage guide →
- Research compound handling guide →
- Peptide reconstitution calculator →
- Research peptide FAQ →
Retatrutide 20mg evidence and reporting resources
Indexed background literature can be searched through PubMed. Researchers should record the exact batch, analytical documentation, preparation conditions, model system, controls, sampling schedule and statistical method. See our research-reading guide for evidence-quality checks.
Research-use notice: Supplied strictly for laboratory and in-vitro research and not intended for human or veterinary use.
Reviews
There are no reviews yet.